PT0V1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy

Clinical Cancer Research

Volumn 14, Issue 9, 2008, Pages 2617-2622

  Morote, Juan ^a   Fernández, Sara ^b   LideAlana ^c   Iglesias, Carmela ^b   Planas, Jacques ^a   Reventós, Jaume ^c   Cajal, Santiago Ramón Y ^b   Paciucci, Rosanna ^c,d   De Torres, Inés M ^b  

^a Cd Sanit y U   (Spain)

^b Hospital Vail d'Hebron   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROSTATE TUMOR OVEREXPRESSED 1 PROTEIN; UNCLASSIFIED DRUG; PTOV1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TISSUE MICROARRAY;

BIOPSY, NEEDLE; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 52049125046     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4987     Document Type: Article

References (18)

1. Benedit P, Paciucci R,Thomson T, et al. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 2001;20:1455-64.
2. Nakamura Y, Suzuki T Igarashi K, et al. PTOV1: a novel testosterone-induced atherogenic gene in human aorta. J Pathol 2006;209:522-31.
3. Santamaría A, Fernández P, Farré X, et al. PTOV1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am J Pathol 2003;162:897-905.
4. Santamaría A, Castellanos E, Gómez V, et al. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts, Mol Cell Biol 2005;25:1900-11.
5. Lee HK, Park UH, Kim EJ, Urn SJ. MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J 2007;26: 3545-57.
6. Haggman M, Macoska J, Wojno K. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol 1997;158:12-22.
7. Epstein J, Potter S. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001; 166:402-10.
8. Zlotta A, Ravic G, Schulman C. Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated intraepithelial neoplasia. Eur Urol 1996;30:249-55.
9. Herawi M, Kahane H, Cavallo C. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol 2006;175:121 -4.
10. Moore C, Karikehalli S, NazeerT. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173:70-2.
11. Morote J, Raventós C, Encabo G, López M, de Torres I. Effect of high grade prostatic intraepithelial neoplasia on total and percent free prostatic specific antigen. Eur Urol 2000;37:456-9.
12. Loeb S, Roehl K.Yu X, Han M, Catalona W. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urology 2007;69: 108-12.
13. Remzi M, Fong Y, Dobrovits M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores bases on patient age and total prostate volume. J Urol 2005;174:1256 - 61.
14. Wu C, Yang X, Tretiakova M, et al. Analysis of methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 2004;35:1008-13.
15. McNealJ, Bostwick D. Intraductal dysplasia: a pre-malignant lesion of the prostate. Human Pathol 1986; 17:64-71.
16. BisharaT, Ramnani D, Epstein J. High-grade prostatic intraepithelial neoplasia on needle biopsy risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Pathol 2004;28: 629-33.
17. Lefkowitz G, Sidhu G, Torre P, Lepor H.Taneja S. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001;58:999-1003.
18. Lefkowitz G,Taneja S, Brown J, Melamed J, Lepor H. Follow-up interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate antigen levels. J Urol 2002;168:1415-8.